DK0579968T3 - 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse - Google Patents

4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse

Info

Publication number
DK0579968T3
DK0579968T3 DK93109965T DK93109965T DK0579968T3 DK 0579968 T3 DK0579968 T3 DK 0579968T3 DK 93109965 T DK93109965 T DK 93109965T DK 93109965 T DK93109965 T DK 93109965T DK 0579968 T3 DK0579968 T3 DK 0579968T3
Authority
DK
Denmark
Prior art keywords
iminoquinolines
preparation
methods
image
formula
Prior art date
Application number
DK93109965T
Other languages
Danish (da)
English (en)
Inventor
Manfred Roesner
Uta-Maria Billhardt-Troughton
Rudolf Bender
Christoph Meichsner
Original Assignee
Hoechst Ag
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Aventis Pharma Gmbh filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0579968T3 publication Critical patent/DK0579968T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK93109965T 1992-06-27 1993-06-22 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse DK0579968T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221210 1992-06-27

Publications (1)

Publication Number Publication Date
DK0579968T3 true DK0579968T3 (da) 2000-03-27

Family

ID=6462017

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93109965T DK0579968T3 (da) 1992-06-27 1993-06-22 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse

Country Status (19)

Country Link
US (1) US5602146A (ja)
EP (1) EP0579968B1 (ja)
JP (1) JP3605123B2 (ja)
KR (1) KR940005577A (ja)
CN (1) CN1083477A (ja)
AT (1) ATE184003T1 (ja)
AU (1) AU670435B2 (ja)
CA (1) CA2099213C (ja)
DE (1) DE59309756D1 (ja)
DK (1) DK0579968T3 (ja)
ES (1) ES2136628T3 (ja)
GR (1) GR3031853T3 (ja)
HU (1) HUT70040A (ja)
IL (1) IL106147A (ja)
MX (1) MX9303843A (ja)
NZ (1) NZ247993A (ja)
PH (1) PH31682A (ja)
TW (1) TW304945B (ja)
ZA (1) ZA934576B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4428932A1 (de) * 1994-08-16 1996-02-22 Hoechst Ag Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9930061D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Quinolone compounds for use in treating viral infections
US20040157804A1 (en) * 2002-10-16 2004-08-12 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
ES2315922T3 (es) * 2004-04-14 2009-04-01 Gilead Sciences, Inc. Analogos de fosfonato de compuestos inhibidores de la integrasa del vih.
EP2116527A4 (en) * 2007-01-23 2011-09-14 Fujifilm Corp OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, METHOD FOR MANUFACTURING THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT
JP5305704B2 (ja) * 2008-03-24 2013-10-02 富士フイルム株式会社 新規化合物、光重合性組成物、カラーフィルタ用光重合性組成物、カラーフィルタ、及びその製造方法、固体撮像素子、並びに、平版印刷版原版
JP6483382B2 (ja) * 2014-09-16 2019-03-13 株式会社Adeka 感光性樹脂組成物、その硬化物
JP6734416B2 (ja) * 2019-02-13 2020-08-05 株式会社Adeka 新規化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US758568A (en) * 1903-05-29 1904-04-26 William E Snediker Wrench.
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
EP0248057B1 (en) * 1985-11-21 1992-05-20 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
US4985439A (en) * 1985-11-21 1991-01-15 Anheuser-Busch Companies, Inc. Glucose tolerance factor and method of making same
US5192768A (en) 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
ATE205837T1 (de) * 1991-04-15 2001-10-15 Aventis Pharma Gmbh Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
ATE184003T1 (de) 1999-09-15
HU9301875D0 (en) 1993-09-28
JP3605123B2 (ja) 2004-12-22
JPH0673012A (ja) 1994-03-15
GR3031853T3 (en) 2000-02-29
HUT70040A (en) 1995-09-28
EP0579968A1 (de) 1994-01-26
US5602146A (en) 1997-02-11
TW304945B (ja) 1997-05-11
CA2099213C (en) 2005-11-29
CN1083477A (zh) 1994-03-09
ES2136628T3 (es) 1999-12-01
MX9303843A (es) 1994-01-31
AU670435B2 (en) 1996-07-18
KR940005577A (ko) 1994-03-21
EP0579968B1 (de) 1999-09-01
CA2099213A1 (en) 1993-12-28
ZA934576B (en) 1994-01-31
PH31682A (en) 1999-01-18
DE59309756D1 (de) 1999-10-07
IL106147A0 (en) 1993-10-20
IL106147A (en) 1997-06-10
AU4149293A (en) 1994-01-06
NZ247993A (en) 1995-11-27

Similar Documents

Publication Publication Date Title
DK0590428T3 (da) Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
ATE269290T1 (de) Benzoylderivate
BG92804A (bg) 4-бензоилизоксазолови производни
YU101791A (sh) Supstituisani ftalidi i heterociklični ftalidi
ES8401037A1 (es) "procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina".
DK0579968T3 (da) 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse
DK0696278T3 (da) Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler
MY132057A (en) Quinoxalinones, a process for their preparation and their use
EP0235064A3 (en) Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing uvb and/or uva
ATE66921T1 (de) Verwendung von triazolylderivate zur bekaempfung von pilzen.
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
ATE89555T1 (de) 3-substituierte 1-(2-halogen-alkoxybenzolsulfonyl)-3-heteroaryl-harnstoffe.
IT1261662B (it) Derivati xantonici, loro preparazione ed attivita'